Relationship of ALC proliferation kinetics to preinfusion disease and BCA. (A-B) Linear regression analysis of lymphocyte expansion parameters and extent of tumor involvement in SRs, showing significant deviation from the 0 slope in SRs (peak ALC, P = .0002; ALC AUC_1mo, P = .005). (C) Proportion of bone marrow involved by leukemia before infusion in various groups. ALC kinetics (mean and 95% confidence interval) of patients who had early loss of BCA (at or before 6 months) (D) compared with patients who never lost BCA (E). (F) Violin plots of peak ALC differences between the two groups (*P = .05, Mann Whitney U test).